İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - fentanylum - cerotti transdermici - fentanylum 4.125 mg, acrylates polymerisatum, trägermaterial: polypropylenum, drucktinte: (blau), ad praeparationem pro 7.5 cm², cum liberatione 25 µg/h. - analgesico - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - fentanylum - cerotti transdermici - fentanylum 8.25 mg, acrylates polymerisatum, trägermaterial: polypropylenum, drucktinte: (blau), ad praeparationem pro 15 cm², cum liberatione 50 µg/h. - analgesico - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - fentanylum - cerotti transdermici - fentanylum 12.375 mg, acrylates polymerisatum, trägermaterial: polypropylenum, drucktinte: (blau), ad praeparationem pro 22.5 cm², cum liberatione 75 µg/h. - analgesico - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - fentanylum - cerotti transdermici - fentanylum 16.5 mg, acrylates polymerisatum, trägermaterial: polypropylenum, drucktinte: (blau), ad praeparationem pro 30 cm², cum liberatione 100 µg/h. - analgesico - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - fentanylum - cerotti transdermici - fentanylum 2.063 mg, acrylates polymerisatum, trägermaterial: polypropylenum, drucktinte: (blau), ad praeparationem pro 3.75 cm², cum liberatione 12 µg/h. - analgesico - synthetika

Avrupa Birliği - İtalyanca - EMA (European Medicines Agency)

zoetis belgium sa - lokivetmab - altri dermatologici preparazioni, agenti per le dermatiti, esclusi i corticosteroidi - cani - trattamento delle manifestazioni cliniche della dermatite atopica nei cani.

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - estradiolum hemihydricum, norethisteroni acetas - cerotti transdermici (kombipackung) - i) fase i pflaster: estradiolum hemihydricum 3.2 mg, excipiens per la preparazione per il 16 cm2 con la liberazione di 50 µg/24 h. ii) fase ii pflaster: estradiolum hemihydricum 3.2 mg, norethisteroni acetas 11.2 mg, excipiens per la preparazione per il 16 cm2 con la liberazione di 50 µg e 170 µg/24 h. - estrogeno-progestinici terapia sostitutiva dopo la menopausa - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - rivastigminum - cerotti transdermici - rivastigminum 6.4 mg, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, polyisobutylenum, silica colloidalis anhydrica, paraffinum perliquidum, trägermaterial: polyethylenum/aluminium polyesterum, polyesterum, ad praeparationem pro 4.3 cm², cum liberatione 4.6 mg/24h. - demenza di tipo alzheimer - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - rivastigminum - cerotti transdermici - rivastigminum 12.8 mg, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, polyisobutylenum, silica colloidalis anhydrica, paraffinum perliquidum, trägermaterial: polyethylenum/aluminium polyesterum, polyesterum, ad praeparationem pro 8.5 cm², cum liberatione 9.5 mg/24h. - demenza di tipo alzheimer - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - rivastigminum - cerotti transdermici - rivastigminum 19.2 mg, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, polyisobutylenum, silica colloidalis anhydrica, paraffinum perliquidum, trägermaterial: polyethylenum/aluminium polyesterum, polyesterum, ad praeparationem pro 12.8 cm², cum liberatione 13.3 mg/24h. - demenza di tipo alzheimer - synthetika